Register entry
Jubilant Cadista Pharmaceuticals Inc.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 48
- Labeller names
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
4848 active NDC listings: 47 human prescription drug, 1 drug for further processing. By marketing category: ANDA 47, DRUG FOR FURTHER PROCESSING 1.
| Dosage form | NDCs |
|---|---|
| tablet | 21 |
| tablet, film coated | 15 |
| capsule | 5 |
| capsule, gelatin coated | 3 |
| tablet, extended release | 3 |
| tablet, delayed release | 1 |
| Route | NDCs |
|---|---|
| oral | 47 |
| Labeller name on the listing | NDCs |
|---|---|
| jubilant cadista pharmaceuticals inc. | 45 |
| jubilant cadista pharmaceuticals,inc. | 2 |
| jubilant cadista pharmaceuticals inc. | 1 |
Catalogue
Marketed products
48| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| CHLORTHALIDONE | Chlorthalidone | tablet, oral | 59746-760ANDA |
| CHLORTHALIDONE | Chlorthalidone | tablet, oral | 59746-761ANDA |
| Carbamazepine | Carbamazepine | tablet, extended release, oral | 59746-789ANDA |
| Carbamazepine | Carbamazepine | tablet, extended release, oral | 59746-790ANDA |
| Carbamazepine | Carbamazepine | tablet, extended release, oral | 59746-791ANDA |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | tablet, film coated, oral | 59746-177ANDA |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | tablet, film coated, oral | 59746-211ANDA |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | tablet, film coated, oral | 59746-735ANDA |
| Escitalopram | Escitalopram Oxalate | tablet, film coated, oral | 59746-279ANDA |
| Escitalopram | Escitalopram Oxalate | tablet, film coated, oral | 59746-280ANDA |
| Escitalopram | Escitalopram Oxalate | tablet, film coated, oral | 59746-281ANDA |
| Eslicarbazepine Acetate | eslicarbazepine acetate | tablet, oral | 59746-717ANDA |
| Eslicarbazepine Acetate | eslicarbazepine acetate | tablet, oral | 59746-718ANDA |
| Eslicarbazepine Acetate | eslicarbazepine acetate | tablet, oral | 59746-719ANDA |
| Eslicarbazepine Acetate | eslicarbazepine acetate | tablet, oral | 59746-720ANDA |
| IRBESARTAN | IRBESARTAN | tablet, oral | 59746-447ANDA |
| IRBESARTAN | IRBESARTAN | tablet, oral | 59746-448ANDA |
| IRBESARTAN | IRBESARTAN | tablet, oral | 59746-449ANDA |
| Losartan Potassium and Hydrochlorothiazide | losartan potassium and hydrochlorothiazide | tablet, film coated, oral | 59746-337ANDA |
| Losartan Potassium and Hydrochlorothiazide | losartan potassium and hydrochlorothiazide | tablet, film coated, oral | 59746-338ANDA |
| Losartan Potassium and Hydrochlorothiazide | losartan potassium and hydrochlorothiazide | tablet, film coated, oral | 59746-339ANDA |
| Losartan potassium Tablets, 100 mg | losartan potassium | tablet, oral | 59746-335ANDA |
| Losartan potassium Tablets, 25 mg | losartan potassium | tablet, oral | 59746-333ANDA |
| Losartan potassium Tablets, 50 mg | losartan potassium | tablet, oral | 59746-334ANDA |
| Methenamine Hippurate | Methenamine Hippurate | tablet, oral | 59746-797ANDA |
| NITROFURANTOIN (monohydrate/macrocrystals) | Nitrofurantoin (monohydrate/macrocrystals) | capsule, oral | 59746-762ANDA |
| PROCHLORPERAZINE MALEATE | Prochlorperazine Maleate | tablet, oral | 59746-113ANDA |
| PROCHLORPERAZINE MALEATE | Prochlorperazine maleate | tablet, oral | 59746-115ANDA |
| - | Pantoprazole Sodium | tablet, delayed release | 59746-284DRUG FOR FURTHER PROCESSING |
| Roflumilast | roflumilast | tablet, oral | 59746-801ANDA |
| Roflumilast | roflumilast | tablet, oral | 59746-802ANDA |
| Sildenafil | sildenafil | tablet, film coated, oral | 59746-434ANDA |
| Sildenafil | sildenafil | tablet, film coated, oral | 59746-435ANDA |
| Sildenafil | sildenafil | tablet, film coated, oral | 59746-436ANDA |
| Sildenafil | sildenafil | tablet, film coated, oral | 59746-471ANDA |
| Tacrolimus | Tacrolimus | capsule, gelatin coated, oral | 59746-798ANDA |
| Tacrolimus | Tacrolimus | capsule, gelatin coated, oral | 59746-799ANDA |
| Tacrolimus | Tacrolimus | capsule, gelatin coated, oral | 59746-800ANDA |
| Terazosin | Terazosin Hydrochloride | capsule, oral | 59746-383ANDA |
| Terazosin | Terazosin Hydrochloride | capsule, oral | 59746-384ANDA |
| Terazosin | Terazosin Hydrochloride | capsule, oral | 59746-385ANDA |
| Terazosin | Terazosin Hydrochloride | capsule, oral | 59746-386ANDA |
| valacyclovir hydrochloride | valacyclovir hydrochloride | tablet, film coated, oral | 59746-324ANDA |
| valacyclovir hydrochloride | valacyclovir hydrochloride | tablet, film coated, oral | 59746-325ANDA |
| valsartan | valsartan | tablet, oral | 59746-360ANDA |
| valsartan | valsartan | tablet, oral | 59746-361ANDA |
| valsartan | valsartan | tablet, oral | 59746-362ANDA |
| valsartan | valsartan | tablet, oral | 59746-393ANDA |
Compare
Other companies listing terazosin hydrochloride
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Proficient Rx LP1 site · 1,729 NDC
- RemedyRepack, Inc1 site · 1,521 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Coupler LLC1 site · 469 NDC
- Biophore India Pharmaceuticals Private Limited1 site · 38 NDC
- Aphena Pharma Solutions - Tennessee, LLC0 sites · 795 NDC
- AvKARE0 sites · 371 NDC
Enquiry
Common questions
- Is Jubilant Cadista Pharmaceuticals Inc. FDA approved?
- Jubilant Cadista Pharmaceuticals Inc. holds no registered establishment of its own; 48 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Jubilant Cadista Pharmaceuticals Inc. make?
- 48 products are listed under Jubilant Cadista Pharmaceuticals Inc. in the openFDA NDC Directory, most often as tablet; tablet, film coated; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.